Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Reactogenicity of Baby-Hib Vaccine in Healthy Adults
NCT05401305Phase 1Completed
- Sponsor
- Saint Petersburg Scientific Research Institute of Vaccines and Serums
- Start
- Jan 2020
- Primary completion
- Mar 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial in Haemophilus influenzae type b infection (Hib) comparing Hib vaccine with Placebo (2 arms). Primary endpoints: Incidence of local adverse events and Incidence of systemic adverse events. Started Jan 2020; status: completed.
02
Drugs
haemophilus influenzae type b vaccine
03
Conditions
Haemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT05401305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05401305.